
Ferric Carboxymaltose Injection
Form: Injectable
Strength: 50 mg /mL vial
Reference Brands: Injectafer (US) and Ferinject (EU)
Category: Nephrology
Ferric Carboxymaltose is an advanced intravenous iron supplement used to treat iron deficiency anemia, especially in patients with chronic kidney disease (CKD) or who are intolerant to oral iron. It ensures rapid iron repletion with fewer doses, making it ideal for hospital and dialysis use. In the US, it is marketed as Injectafer, while in the EU, it is known as Ferinject. Widely trusted for its safety and efficacy, Ferric Carboxymaltose is in high demand across Pharma B2B markets. Partner with GMP-certified Ferric Carboxymaltose manufacturers and suppliers to offer this essential therapy worldwide.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Related Products
Calcitriol
Strength: Capsules:0.25 mcg, 0.5 mcg; Injection:1 mcg/mL
Form: Capsules & Injection
Reference Brands: Rocaltrol®(EU & US), Calcijex® (US)
View DetailsParicalcitol Generics
Strength: Capsules:1mcg, 2mcg, 4 mcg & Injection: 2mcg/mL , 5mcg/mL
Form: Capsules and Injection
Reference Brands: Zemplar®(US &EU)
View DetailsMethoxy Polyethylene Glycol-Epoetin Beta Generics
Strength: 25–250 mcg
Form: Solution for Injection
Reference Brands: Mircera® (US &EU)
View Details